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Abstract: 
 
Objective: US long-haul truck drivers experience a wide array of excess cardiometabolic disease 
(CMD) risks unique to their occupation. How these risks translate to, and potentially induce, 
elevations in the clinical CMD risk profile of this population is unknown. 
 
Methods: A non-experimental, descriptive, cross-sectional design was employed to collect 
anthropometric and biometric data from 115 long-haul truckers to generate for the first time a 
comprehensive CMD risk marker profile, which was then compared with the general US 
population. The relationships between CMD risk markers and CMD outcomes were examined 
for both populations. 
 
Results: The long-haul trucker sample presented elevated CMD risk markers, generally scoring 
significantly worse than the general population. Associations between CMD risk markers and 
disease states varied between both populations. 
 
Conclusions: US long-haul truck drivers' distinctive CMD risk profile indicates occupationally-
linked CMD pathogenesis. 
 
Keywords: cardiometabolic disease | long-haul truck drivers | metabolic syndrome | type 2 
diabetes mellitus | National Health and Nutrition Examination Survey (NHANES) 
 
Article: 
 
Cardiometabolic disease (CMD) risk refers to the presence of a diverse set of indicators that are 
linked to cardiovascular and metabolic disease outcomes. Multiple markers may be utilized to 
assess CMD risk, but metabolic syndrome represents a cluster of clearly defined, specific risk 
factors: while each of these risk factors has an independent effect on CMD risk, they also 
function synergistically to elevate such risk.1,2 Metabolic syndrome is diagnosed if subjects meet 
three or more of the following five criteria: abdominal obesity (waist circumference >=102 cm 
for men and >=89 cm for women); high triglycerides (>=150 mg/dL for men and women); low 
high-density lipoprotein (HDL) cholesterol (<40 mg/dL for men and <50 mg/dL for women); 
high blood pressure (>=130/85 for men and women); and high glucose (>=100 mg/dL for men 
and women).3 
 
Obesity has been well established as a risk marker for CMD.4 Novel measures of body 
composition that assess abdominal deposits of adiposity are associated with hypertension, 
diabetes, and cardiovascular disease.2,4 Abdominal obesity is commonly measured non-
invasively by waist circumference (WC) or sagittal abdominal diameter (SAD).5,6 Blood pressure 
and blood lipids constitute traditional CMD risk markers.1,7,8 Blood glucose levels may indicate 
type 2 diabetes mellitus, itself associated with cardiovascular disease risk.9 Finally, CMD risk 
markers may indicate systemic low-grade inflammation associated with obesity. Due to its 
impact on the inflammatory system, obesity generates a systematic inflammatory response.2 At 
the cellular level, obesity results in adipocyte hypertrophy, which can induce hypoxia and 
cellular apoptosis and shift the macrophage phenotype of adipose tissue from anti-inflammatory 
to pro-inflammatory.10 This transition in macrophage phenotype induces the production of 
cytokines such as Interleukin-6 (IL-6).5 Chronic elevations in IL-6 that occur with inflammation 
are associated with elevated CRP levels.5,11 Systemic low-grade inflammation has been 
hypothesized to be the linkage between obesity and CMD outcomes.5,10–12 
 
In the US, cardiometabolic health is generally poor. Heart disease, one CMD outcome, is the 
leading cause of death.13 Type 2 diabetes mellitus, another CMD outcome, has steadily increased 
in prevalence over the past several decades.9 Because type 2 diabetes mellitus is a major 
cardiovascular disease risk factor, and because mortality rates from cardiovascular disease are 
two to four times higher among adults with type 2 diabetes mellitus,8,9 cardiovascular disease 
and type 2 diabetes mellitus may function with other CMD risk factors to synergistically increase 
disease burden among affected populations. Numerous factors influence the CMD risk of the 
general population. Non-modifiable risk factors include age, race/ethnicity, sex, and genetics.1,9 
Modifiable factors include sleep patterns, healthcare access, smoking, dietary choices, and 
physical activity patterns.9,14,15 The workplace provides additional modifiable risk factors, such 
as work hours and scheduling, job strain and stress, and physical exertion.16 
 
Commercial drivers—and in particular, long-haul truck drivers—face numerous and interrelated 
CMD risks, and thus exhibit heightened levels of key CMD risk markers. For example, elevated 
levels of hypertension, dyslipidemia, and obesity (as measured by both body mass index [BMI] 
and abdominal obesity) have been found among long-haul truck drivers.17–19 Unique work-
related experiences of long-haul truck drivers exacerbate their CMD risk, such as work 
organization and workplace characteristics, including work hours, shift work, fatigue, job strain, 
stress, and availability of health resources.19,20 This unique constellation of CMD risk factors 
enhances long-haul truck drivers’ likelihood of developing multiple chronic health conditions, 
including type 2 diabetes mellitus, cardiovascular disease, and other cardiometabolic 
comorbidities.21,22 These outcomes generate related comorbidities that can increase accident risk 
and reduce commercial drivers’ life expectancies.23 
 
Elucidating CMD risk among US long-haul truck drivers is needed; however, because no 
existing epidemiological studies of long-haul truck drivers have simultaneously collected 
anthropometric and biometric data, a comprehensive clinical picture of CMD risk among long-
haul truck drivers in the US is not available. Thus, our paper has three objectives: (1) to generate 
for the first time a CMD risk marker profile for long-haul truck drivers based on primary data 
collected; (2) to compare the CMD risk marker profile for long-haul truck drivers to that of the 
general US population using a national dataset; and (3) to examine relationships between CMD 
risk markers and CMD outcomes. To accomplish these three objectives, we use two datasets. 
The first dataset consists of a sample of long-haul truck drivers and is used in pursuit of all three 
objectives. The second dataset, which is used in pursuit of objectives two and three, is the 
National Health and Nutrition Examination Survey (NHANES), which consists of a large 
representative sample and combines both interviews and physical examinations.24 The NHANES 
was selected because of its quality of data, sample size, and degree of overlap with the long-haul 
truck driver dataset on key variables related to CMD risk and outcomes.24 We hypothesized that: 
(1) long-haul truck drivers have heightened CMD risk markers compared with that of the general 
population; and (2) traditional, body composition, and inflammatory CMD risk markers of both 
long-haul truck drivers and the general US population will be significantly associated with CMD 
outcomes. 
 
METHODS 
 
Study Design and Procedures 
 
The study was approved by the Institutional Review Board (IRB) of the University of North 
Carolina at Greensboro. A non-experimental, descriptive, cross-sectional design was employed 
to collect survey and biometric data from 262 long-haul truck drivers over a period of 6 months 
at a large-size TravelCenters of America (TA) truckstop located in North Carolina. This location 
constituted a representative national truckstop: because of the transient nature of long-haul 
trucking, and because of the consistent and high level of trucking activity at this location, this 
site was representative of typical US truckstops. Permission to conduct the study at the truckstop 
was requested and granted by the TA Corporate Office. 
 
Field researchers trained in survey and biometric data collection and phlebotomy spent 
approximately 3 or 4 days each week at the truckstop in two teams. One team of two to four 
researchers remained at the TA truckstop from approximately 6 to 10 pm to collect survey and 
biometric data. Signs regarding the study were posted at strategic locations around the truckstop. 
Using intercept techniques, researchers approached drivers and asked screening questions to 
assure they were long-haul truck drivers and that they had an overnight layover at the truckstop. 
During this conversation, study details, including the voluntary nature of participation, cash 
incentives, and the necessary fasting for blood draw the next morning, were explained. Those 
drivers able and willing to return to the same location between 4 and 8 am the next morning were 
enrolled and appointments were made for the following morning. Enrolled drivers were then 
asked to sign an informed consent form and were allowed to use aliases for greater 
confidentiality and in some cases anonymity. In this manner, drivers’ biometric measures were 
collected and drivers were paid a $10 cash incentive. They were given appointment cards and 
told they would receive another $10 the following morning after the blood draw (along with a 
small snack). 
 
Of the 262 long-haul truck drivers that completed questionnaires and anthropometric measures, 
115 long-haul truck drivers returned for blood draws the following morning. The second team of 
one to two certified phlebotomists arrived early at the truckstop, set up their equipment, and, 
using a medical privacy screen and fluorescent lamp, proceeded to collect blood samples from 
drivers. Following the blood draws, appointment cards were collected and incentives and small 
snacks were given to drivers. Blood samples were then stored in a portable centrifuge for 
delivery to the university laboratory later that morning. With Type I error set at 0.05 and power 
at 90%, our sample size was anticipated to enable us to conduct appropriate statistical analyses, 
including examining significant differences among independent and outcome variables. 
 
Survey and Sample Characteristics 
 
Data for demographic, behavioral, and health status variables that could potentially be related to 
CMD risk among long-haul truck drivers were collected. We developed the Trucker Sleep 
Disorders Survey from insights gleaned from other key instruments, relevant literature, and our 
previous work with long-haul truck drivers.25–28 Key variables for this study included diabetic 
status, cardiovascular problems, prescribed medication use, age, race/ethnicity, and tenure in the 
profession. Diabetes diagnosis and cardiovascular health problem information was provided via 
self-report. 
 
Anthropometric Measures 
 
Given the high prevalence of overweight and obesity among long-haul truck drivers, we were 
interested in identifying simple anthropometric measures that could be utilized in this group to 
screen drivers with the highest risk for long-term health complications. Using a privacy screen in 
a low-traffic area of the truckstop, the weight of each driver was recorded in kilograms to the 
nearest tenth using an Elite XXL scale. Height was measured to the nearest centimeter using a 
portable stadiometer (Seca, Chino, CA). BMI (kg/m2) was calculated and rounded to the nearest 
tenth. Waist circumference was assessed using a Gulick II tape measure with tension indicator 
and SAD measures were taken at the level of the umbilicus [approximating the L4–L5 level of 
the spine] using a Rosscraft Campbell caliper #20 (Vancouver, BC) and values recorded to the 
nearest tenth of a centimeter. Each measure was taken two times and averaged. 
 
Blood Pressure 
 
Participants rested quietly for 5 minutes with their arm supported at heart level and their feet on 
the floor, as outlined by the Seventh Report of the Joint National Committee on Prevention, 
Detection, Evaluation and Treatment of High Blood Pressure.29 Manual cuff blood pressure 
measurements were repeated two times with 5 minutes between measures, and values for systolic 
and diastolic blood pressure were averaged from the two measures. 
 
Blood Draws and Specimens 
 
Following occupational safety and health administration procedures,30 blood was taken from the 
antecubital space in either arm using aseptic technique by a certified phlebotomist. Blood was 
collected in red top tubes and allowed to clot at room temperature for 15 to 20 minutes. Using a 
portable centrifuge (LW Scientific E8 Portafuge, Atlanta, GA), blood samples were spun at 3000 
rpm for 15 minutes and then transported on ice to the laboratory. To limit freeze/thaw cycling, 
serum was divided into aliquots and stored at -80 °C for future analysis. 
 
We requested that participants fast for 8 hours prior to the blood draw. Because of the scheduling 
of long-haul truck drivers, which are demanding and structured around 10 hours breaks in 
between driving shifts,31 we realize that it was not possible for all participants to fast for the 
requested 8 hours. Based on the available literature, which suggests ambiguity in terms of 
standardized required fasting periods for our various blood analyes,32 and given the 
impracticality of requiring longer fasting periods of the drivers in our sample, we felt that this 
fasting time was appropriate. In comparison, the NHANES sample used for comparisons in this 
study only fasted for approximately 6.49 hours. 
 
Blood Analysis 
 
All samples are analyzed in duplicate with appropriate quality controls in the University's 
Exercise Physiology Laboratory using commercially available ELISA systems and the EPOCH 
plate reader (BioTek, Winooski, VT). Specifically, lipid profiles (total cholesterol, triglycerides, 
low-density lipoproteins, and high-density lipoproteins), were assayed using colorimetric 
reagents using protocols specified by the manufacturer (Wako USA, Richmond, VA). Glucose 
was assayed using a colorimetric assay (Kit no. # 10009582; Caymen Chemical, Ann Arbor, 
MI). The range of this assay is 2.5 to 25 mg/dL and all serum samples were diluted 1:5 prior to 
analysis. Samples above the detection limit of 25 mg/dL were further diluted and reanalyzed. 
Tolerance for duplicate sample variance was set at 15% and samples were re-analyzed if the 
coefficient of variance (CV) for the duplicate was greater than 15%. 
 
The National Health and Nutrition Examination Survey 
 
The NHANES provided an excellent comparison sample to elucidate the CMD risk of long-haul 
truck drivers versus the general US population. The NHANES is collected annually through 
household screenings to assess for meeting predetermined criteria for inclusion and involves both 
an interview and physical examination.33 Beginning in 2011, there was no age limit for inclusion, 
and the NHANES initiated purposive oversampling of minority populations, including, 
Hispanics, African Americans, Asians, Whites at or below 130% of the federal poverty level, and 
Whites 80 years of age or older.34 The interview portion includes demographic, health, and 
nutrition information, with physical measurements and blood collections including blood and 
urine specimens for laboratory testing.33 The final sample for the 2011 to 2012 sample, which 
was the reference sample for the bulk of our comparisons included 9338 people.33 Since our 
long-haul truck driver sample featured only men 18 and older, we filtered the NHANES dataset 
to match these demographic characteristics. For all comparisons except for high-sensitivity C-
reactive protein (hs-CRP), the NHANES 2011 to 2012 cohort was used, which included 2820 
subjects. Because this cohort did not include hs-CRP measure, we utilized the data from the 2009 
to 2010 cohort, which included 2561 subjects. 
 
Statistical Analysis 
 
We first performed descriptive analyses to create a profile of the long-haul truck driver sample in 
comparison to the NHANES data. Descriptive statistics included age, job tenure (as years in 
profession), race/ethnicity (white vs. non-white), and the use of prescription medications. Next, 
we conducted descriptive analyses of CMD risk for each sample to include traditional (blood 
pressure; HDL, low-density lipoprotein (LDL), non-HDL, and total cholesterol; triglycerides; 
and blood glucose), body composition (BMI, WC, and SAD), and inflammatory (hs-CRP) risk 
markers. We then recorded the means and standard deviations, along with the sample size 
information, to utilize for summary independent-sample t-tests. These t tests analyzed statistical 
significance in mean differences between the two samples. The outcome variables used for 
further CMD risk analyses included metabolic syndrome, diabetes, and cardiovascular health 
problems (for long-haul truck drivers) or coronary heart disease (for the NHANES cohort) 
diagnoses. Metabolic syndrome was diagnosed if subjects met three or more of the five 
diagnostic criteria discussed in the introduction (or were prescribed medication for lipids, BP, or 
glucose). We then tested for group differences between the long-haul truck driver and NHANES 
samples using chi-squared ([chi]2) tests. Using the CMD risk and outcome variables, we 
performed partial correlation analyses for both samples to compare associations; with these 
analyses we controlled for prescription medication use and weighted the data for race/ethnicity 
due to the discrepancies in racial make-up of the two samples (51.0% white in the long-haul 
truck driver sample vs. 37.1% white in the NHANES sample). This was most likely to due to the 
aforementioned purposive oversampling of minority populations within NHANES. All statistical 
analyses were performed using SPSS 23.0.35 
 
RESULTS 
 
While many long-haul truck drivers agreed to participate in the questionnaire and anthropometric 
portion of the study, slightly fewer than half these drivers (N = 115, 43.9%) returned the 
following morning for a fasted blood draw. We first performed [chi]2 tests to assess for non-
response bias among the long-haul truck drivers who did not return for the morning blood draw 
versus who did return for the morning blood draw. Three subjects from the non-blood draw 
group had missing anthropometric variables and were excluded from the analysis. We found that 
there were no statistically significant differences between the two groups. When comparing 
anthropometrics or resting blood pressure, the group that returned for a blood draw was not 
significantly different on any variable compared with the individuals who did not return for a 
blood draw the following morning. The drivers who returned for a blood draw in the morning 
were slightly older (47.8 vs. 45.7 years old), had slightly larger WC (115 cm vs. 114.6 cm) and 
SAD (32.4 cm vs. 32.2 cm), and had slightly higher resting systolic (129.3 mm Hg vs. 128.5 mm 
Hg) and diastolic blood pressure (82.8 mm Hg vs. 80.6 mm Hg), but none of these differences 
were significant. The drivers who returned for blood draws had identical BMI (33.4) as those 
who did not. These comparisons were similarly reported in a previous study which used the same 
dataset.36 
 
The long-haul truck driver and NHANES samples were very similar across several measures (see 
Table 1). There were no statistically significant differences between the two samples based on 
age, years in profession, or the use of prescription medications. The mean age of the long-haul 
truck driver sample was 47.8 (standard deviation [SD] = 9.7) and the mean age of the NHANES 
cohort was 47.9 (SD = 18.4). Long-haul truck drivers reported working in the profession for an 
average of 14.4 years (SD = 11.3), while those in the NHANES cohort reported working in their 
respective professions for an average of 15.1 years (SD = 12.9). Sixty-seven percent of the long-
haul truck driver sample reported using prescription medications, compared with 69.1% of the 
NHANES sample. There were statistically significant differences between the two samples based 
on race/ethnicity: of the truck driver sample, 51% were whites, compared with 37.1% of the 
NHANES sample.  
 
Table 1. Comparison of Demographics and Prescribed Medication Use of Long-Haul Truck 
Driver Sample and NHANES (Filtered) 2011 to 2012 Data 
 
 NHANES, National Health and Nutrition Examination Survey; NS, not significant; SD, 
standard deviation.  
 a P < 0.01. 
 
The long-haul truck driver sample was significantly higher than the NHANES sample across 
most CMD risk markers (Table 2). Mean differences of 5.79 for BMI (t = 7.42, P < 0.01), 23.19 
cm for WC (t = 11.38, P < 0.01), and 10.28 cm for SAD (t = 21.57, P < 0.01) were found across 
the body composition measures, with the long-haul truck driver sample measuring higher for all 
three. With regards to blood pressure, the means of both the systolic and diastolic readings were 
significantly greater among the long-haul truck driver sample, with a mean difference of 8.22 
mm Hg for systolic (t = 4.40, P < 0.01) and 14.73 mm Hg for diastolic (t = 11.54, P < 0.01). The 
NHANES sample was significantly higher for HDL cholesterol (M = 17.07 mg/dL, t = 13.45, P 
< 0.01), total cholesterol (M = 14.64 mg/dL, t = 3.78, P < 0.01), and blood glucose (M = 18.94 
mg/dL, t = 6.25, P < 0.01). The long-haul truck driver sample had significantly greater means for 
triglycerides (M = 44.70 mg/dL, t = 4.88, P < 0.01) and, as reported in a previous study using the 
same dataset,36 for hs-CRP (M = 8.47 mg/L, t = 40.52, P < 0.01).  
 
Table 2. Comparisons of Cardiometabolic Risk Markers of Long-Haul Truck Driver Sample and 
NHANES (Filtered) 2011 to 2012 Data 
 
 BP, blood pressure; BMI, body mass index; CMD, cardiometabolic disease; NHANES, 
National Health and Nutrition Examination Survey; NS, not significant; SD, standard deviation.  
 * Used NHANES 2009 to 2010 data for hs-CRP.  
 † Comparisons are expressed in percentages and percentage differences.  
 a P < 0.01. 
 
For the three CMD outcome variables (diabetes diagnosis, metabolic syndrome, and 
cardiovascular problems) (see Table 2), 18.3% of the long-haul truck driver sample had been 
diagnosed with diabetes, compared with only 7% of the NHANES sample. Nearly 74% (73.7%) 
of the long-haul truck driver sample met the criteria for metabolic syndrome, versus only 33.8% 
of the NHANES sample. There were significant differences between the two samples for both 
diabetes diagnosis and meeting the criteria for metabolic syndrome (P < 0.01 for both). Finally, 
4.3% of the long-haul truck driver sample reported being diagnosed with cardiovascular health 
problems, while only 3.6% of the NHANES sample had been diagnosed with coronary heart 
disease; however, this was not a statistically significant difference. 
 
Table 3. Partial Correlations for both Long-Haul Truck Drivers Sample and NHANES 2011 to 
2012 Data (Controlling for Prescribed Medication Use and Weighed for Race/Ethnicity) 
 
 BP, blood pressure; BMI, body mass index; NHANES, National Health and Nutrition 
Examination Survey.  
 a P < 0.05.  
 b P < 0.01. 
 
When examining the partial correlations between the three CMD outcome variables and the 
CMD risk markers (Table 3), there were interesting similarities and differences between the two 
samples. For diabetes diagnosis, there was little association with the risk markers within the 
NHANES sample; however, with the long-haul truck driver sample there were significant 
correlations with measures of WC (r = 0.26, P < 0.05), SAD (r = 0.24, P < 0.05), non-HDL 
cholesterol (r = -0.34, P < 0.05), total cholesterol (r = -0.32, P < 0.05), and diastolic BP (r = -
0.41, P < 0.01). For metabolic syndrome, there were several modest to relatively strong 
associations with the CMD risk markers. Statistically, significant associations for long-haul truck 
drivers included: BMI (r = 0.32, P < 0.01), WC (r = 0.28, P < 0.05), SAD (r = 0.35, P < 0.011), 
HDL (r = -0.30, P < 0.01), triglycerides (r = 0.22, P < 0.05), systolic blood pressure (r = 0.31, P 
< 0.01), and diastolic blood pressure (r = 0.45, P < 0.01). For the NHANES cohort, statistically 
significant associations included BMI (r = 0.34, P < 0.05), WC (r = 0.35, P < 0.05), SAD (r = 
0.36, P < 0.05), LDL (r = 0.37, P < 0.05), glucose (r = 0.47, P < 0.01), and triglycerides (r = 0.52, 
P < 0.01). Finally, for the long-haul truck driver sample, only non-HDL cholesterol (r = 0.23, P < 
0.05) and total cholesterol (r = 0.23, P < 0.05) held significant correlations with cardiovascular 
health problems; similarly, for the NHANES sample, the only two significant correlations with 
coronary heart disease were non-HDL cholesterol (r = -0.14, P < 0.05) and total cholesterol (r = -
0.15, P < 0.05). 
 
DISCUSSION 
 
Heightened CMD risk among long-haul truck drivers has far-reaching consequences. Among 
long-haul truck drivers, heightened CMD risk is associated with excessive daytime sleepiness, 
disordered sleep, and workplace fatal and nonfatal injuries.37–40 Cumulatively, heightened CMD 
risk contributes to life expectancies approximately 16 years shorter than the general US 
population.23 The trucking industry is burdened by excessive healthcare costs and reduced labor 
productivity associated with CMD risk and associated outcomes.20 Given the importance of the 
trucking industry to the US economy, poor long-haul truck driver health has negative impacts for 
multiple stakeholders, such as insurance companies, healthcare systems, manufacturing and 
warehousing firms, and truckstop companies.20 Further, CMD risk has implications for public 
safety, as factors such as hypertension, obesity, diabetes, and cardiovascular disease impair key 
safe driving abilities required of long-haul truck drivers.20 
 
These findings present a comprehensive clinical picture of CMD risk among long-haul truck 
drivers in the US for the first time. The long-haul truck driver sample presented elevated CMD 
risk compared with established normal ranges for CMD risk markers. On average, the long-haul 
truck driver sample was pre-hypertensive (120 to 139 mm Hg systolic; 80 to 89 mm Hg 
diastolic) and exhibited undesirable LDL cholesterol (>100 mg/dL), HDL cholesterol (<60 
mg/dL), and triglyceride (>150 mg/dL) levels.41,42 The long-haul truck driver sample was also, 
on average, obese (BMI >=30) and had risk-indicative adipose tissue distribution (WC >102 cm; 
SAD >30 cm).43,44 Finally, and as indicated in a previous study using the same dataset,36 the 
mean hs-CRP level in the long-haul truck driver sample was far above the normal range (<=3.0 
mg/L), indicating significant inflammation.45 Long-haul truck drivers from other countries 
exhibit similarly elevated CMD risk profiles. For example, among Brazilian long-haul truck 
drivers, elevated levels of hypertension, dyslipidemia, blood glucose, obesity, abdominal obesity, 
and metabolic syndrome have been observed compared with established ranges of CMD risk.21,46 
Studies have found elevated BMIs of long-haul truck drivers in Canada, as compared with a 
national dataset from the Canadian Community Health Survey, and in Italy, compared with bus 
drivers,47,48 as well as elevated cardiovascular disease outcomes among long-haul truck drivers in 
Sweden, matching similar patterns of other transportation workers.49 Other studies have also 
shown US long-haul truck drivers to have elevated levels of metabolic syndrome and diabetes 
compared with the US adult working population.17,18 
 
In comparison to the general US population from NHANES, the long-haul truck driver sample 
presented elevated CMD risk markers and had higher diagnosis rates for metabolic syndrome 
and diabetes, confirming our first hypothesis. However, there were some exceptions; namely, 
total cholesterol and blood glucose levels. Because of data incompatibilities, it was not possible 
to detect whether cholesterol differences are attributable to medication usage alone. While the 
long-haul truck driver sample had lower total cholesterol, measures of LDL and non-HDL 
cholesterol were higher, and HDL was lower; thus, their overall cholesterol profile indicates 
elevated atherosclerotic,50 and thus elevated cardiometabolic, risk compared with the NHANES 
sample. Regarding the lower levels of blood glucose among the long-haul truck driver sample, 
drivers who are diagnosed with type 2 diabetes and are insulin dependent are subject to stringent 
federal regulations which require them to apply for a diabetes exemption and mandate that they 
exhibit control of their disease 51,52; thus, drivers’ livelihoods are dependent on controlling their 
glucose levels, and those who are unable to do so are medically disqualified from the profession. 
This highlights the possibility of federal policy to impact CMD risk and outcomes among long-
haul truck drivers. The long-haul truck driver sample had a slightly greater percentage on 
diabetes medications, which may also explain the comparatively lower levels of blood glucose. 
The higher diabetes medication use is likely attributable to the higher diabetes diagnosis rate 
among the long-haul truck driver sample, which suggests that screening for diabetes catalyzes 
efforts among these individuals to manage their blood glucose levels. Also, the NHANES fasting 
times were nearly an hour and a half shorter than those of the long-haul truck drivers; hence, it is 
possible that equivalent fasting times would have negated these differences. 
 
The overall degree of CMD risk of the long-haul truck drivers compared with the NHANES 
sample suggest the powerful influence of unique occupational characteristics endured by long-
haul truck drivers. Other studies have implicated the role of long work hours, unpredictable 
schedules, shift work, job strain, and lack of health-supportive resources (eg, healthful foods; 
truck stop gyms) in the workplace 53–56 as factors which induce CMD risk among long-haul truck 
drivers. Extant long-haul truck driver health and wellness programs address these factors rarely, 
if at all.57 For example, many long-haul trucking companies provide programs which target one 
area of concern, such as Schneider National, Inc. and Gordon Trucking, Inc., which had 
programs targeting sleep apnea through screening and treatment.58,59 Others, such as those 
provided by JB Hunt, Inc. and Con-Way Freight, Inc., are more comprehensive; however, even 
these focus on individual behavior and fail to address critical elements of work organization, 
such as scheduling.58,60 Interventions to curb excess CMD risk and outcomes among drivers 
should target these vital elements of workplace and work organization. 
 
The distinct relationships between CMD risk markers and CMD outcomes for long-haul truck 
drivers provide potentially useful predictive information for clinicians, as unique aspects of the 
long-haul trucking profession may differentially induce CMD risk compared with the general US 
population. However, while several significant associations were found, particularly with regard 
to metabolic syndrome and cardiovascular disease outcomes, the unevenness of some of the 
associations was relatively surprising with respect to our second hypothesis. One such 
association is between glucose and diabetes, which was a nonsignificant but positive correlation 
among the long-haul truck drivers. These are likely partially explained by medication usage, 
which was relatively higher among the long-haul truck driver sample compared with the 
NHANES sample. Also, as discussed previously, long-haul truck drivers’ livelihoods are 
dependent on controlling their glucose levels, and those who are unable to do so are medically 
disqualified from the profession. This may mean that, not only are drivers especially vigilant in 
controlling this measure of CMD risk after being diagnosed with diabetes, but that those that are 
unsuccessful in doing so are forced out of the profession through the revocation of their medical 
certification. 
 
Other takeaways among the long-haul truck drivers’ sample are the significant associations 
between CMD risk markers and diabetes diagnosis, many of which are components of metabolic 
syndrome. It appears that metabolic syndrome and diabetes are indeed associated with similar 
factors, suggesting the syndemic nature of both diseases. The pattern of nonsignificance of 
associations between glucose and metabolic syndrome further suggests, within the context of the 
regulatory environment, the vigilance of drivers in controlling their glucose levels. In contrast, in 
the NHANES sample, none of the CMD risk markers were significantly associated with diabetes 
diagnosis, and in fact these risk factors were negatively correlated. This may also be a function 
of medication usage, which was nearly 70%. Finally, there were relatively few significant 
associations between CMD risk markers and cardiovascular outcomes. Among the long-haul 
truck drivers and NHANES samples, the significance of non-HDL cholesterol and total 
cholesterol highlights the importance of these cholesterol types in arteriosclerosis 50 and suggests 
that these types of cholesterol may be the most relevant in predicting later cardiovascular disease 
outcomes in both populations.7,61 
 
Many of the unexpected patterns of associations between CMD risk markers and CMD outcomes 
among our long-haul truck driver sample are likely influenced by our research design, which is 
cross-sectional and represents a “snapshot” in time. To elucidate the relationship between CMD 
risk and long-haul truck driver outcomes, a longitudinal design is required to allow CMD risk 
and outcome dynamics to develop over time within a cohort of drivers. Such a study would also 
facilitate understanding of the unique interplay of CMD risk and outcomes within the context of 
long-haul trucking. For example, it is possible that CMD outcomes may be masked in our data 
by medical examination requirements imposed on long-haul truck drivers. Federal policy 
currently dictates that long-haul truck drivers must undergo a screening process at least once 
every 2 years.17 As the accumulation of CMD risk factors manifests as disease states, long-haul 
truck drivers are medically disqualified from the profession and thus leave long-haul truck 
driving. Should this be the case, our sample—consisting of medically qualified long-haul truck 
drivers—may not have captured the bulk of drivers who are in disease states as a result of a 
career in a CMD-inducing occupation. A longitudinal study would also answer additional, and 
potentially confounding, questions, such as whether there is a selection bias among those who 
choose to enter the long-haul trucking profession in the first place. It is possible that there is a 
subset of the population who finds the default health behaviors—namely, the consumption of 
high-fat and high-calorie foods and the sedentary lifestyle 55—of the long-haul truck driving 
profession appealing. Such default behaviors are propagated by the lack of healthful food options 
and opportunities for exercise at long-haul truck driver worksites.56 While the medical 
certification process likely screens out many of these individuals from entering the profession, 
particularly those who exhibit CMD disease states,62 individuals with a propensity toward such 
behaviors may find these tendencies exacerbated upon entering the profession, with the array of 
CMD risk and outcomes highlighted in the current study being the result. 
 
There are three primary limitations of the current study. First, the overall sample size is relatively 
small, with 262 long-haul truck drivers, 115 of whom participated in blood draws. While a larger 
sample size may have increased our likelihood of finding additional relationships, the 
congruency of our findings with other studies involving long-haul truck drivers indicates that our 
sample was highly representative of the population. Second, the potential for selection bias is an 
important limitation to consider when interpreting our results. Drivers may have refused to 
participate for myriad reasons. For example, giving the increasingly-stringent medical 
requirements that drivers must meet to operate a commercial motor vehicle in the US, drivers 
may have been concerned that results from the current study could have potentially resulted in 
medical disqualification or termination. Drivers may also have been leery of releasing any 
personal information to a government entity, including the University conducting this study. Our 
own extensive experience with collecting data from this population has indicated the presence of 
a certain level of mistrust among many drivers, and similar feedback was received from non-
participating drivers informally in the current study as well. These potential selection biases were 
discussed in a previous study using the same dataset.36 Third, we employed a sampling technique 
that involved blood draws in an actual long-haul truck driver workplace (at a truckstop). While 
this minimized the barriers to participation and likely increased the willingness of individuals to 
be involved in the study, it limited the amount of time drivers were able to fast prior to the blood 
draw. Although these shorter fasting times may slightly have altered our blood values, they are 
representative of the normal schedules maintained by these individuals. Further, because the 
NHANES sample which was used for comparison had similar or shorter fasting windows, and 
because shorter fasting windows generally result in artificially high readings of many of the 
CMD risk indicators used in this study,32 our analyses may in fact underestimate the disparities 
in CMD risk between long-haul truck drivers and the general US population. 
 
In conclusion, this sample of US long-haul truck drivers presented elevated CMD risk markers, 
providing a comprehensive CMD risk marker profile for the first time. Heightened CMD risk 
compared with the general US population indicates occupationally-linked CMD pathogenesis. 
As the trucking industry continues to be highly competitive, as the labor pool of commercial 
drivers continues to shrink, and as regulatory pressure continues to increase, measures to reduce 
the CMD risk of long-haul truck drivers and its adverse consequences are imperative. These 
measures should address unique occupational characteristics experienced by long-haul truck 
drivers. 
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